These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10022667)

  • 1. Nocturnal acid breakthrough in subjects taking PPI b.i.d.
    Savarino V; Mela GS; Vigneri S
    Am J Gastroenterol; 1999 Feb; 94(2):536-7. PubMed ID: 10022667
    [No Abstract]   [Full Text] [Related]  

  • 2. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.
    Peghini PL; Katz PO; Bracy NA; Castell DO
    Am J Gastroenterol; 1998 May; 93(5):763-7. PubMed ID: 9625124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid control and regression of Barrett's esophagus: is the glass half full or half empty?
    Castell DO; Katz PO
    Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders.
    Castell D
    Expert Opin Pharmacother; 2005 Nov; 6(14):2501-10. PubMed ID: 16259581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H+/K+-ATPase (proton pump) inhibitors dampen increased cough reflex: more than gastric acid suppression.
    Chung KF
    Clin Exp Allergy; 2005 Mar; 35(3):245-6. PubMed ID: 15784098
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
    Katz PO; Koch FK; Ballard ED; Bagin RG; Gautille TC; Checani GC; Hogan DL; Pratha VS
    Aliment Pharmacol Ther; 2007 Jan; 25(2):197-205. PubMed ID: 17229243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal gastric acid breakthrough on proton pump inhibitors.
    Savarino V; Mela GS
    Aliment Pharmacol Ther; 1999 Jul; 13(7):977-8. PubMed ID: 10383534
    [No Abstract]   [Full Text] [Related]  

  • 8. Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?
    Kinoshita Y; Ishihara S
    J Gastroenterol; 2004 Jan; 39(1):92-3. PubMed ID: 14767746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cause and prevention of nocturnal gastric acid breakthrough].
    Adachi K; Kinoshita Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():779-83. PubMed ID: 11979888
    [No Abstract]   [Full Text] [Related]  

  • 10. Barrett's esophagus: acid suppression, but no regression.
    Bozymski EM; Shaheen NJ
    Am J Gastroenterol; 1997 Apr; 92(4):556-8. PubMed ID: 9128299
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role and significance of acid suppressive drugs in the eradication of H. pylori].
    Yakabi K; Tsuda K; Ogawa K; Hoshika Y; Tomono H; Nakamura T
    Nihon Rinsho; 1999 Jan; 57(1):53-60. PubMed ID: 10036935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroxine in goiter, H. pylori infection, and gastritis.
    Dietrich JW; Boehm BO
    N Engl J Med; 2006 Sep; 355(11):1177; author reply 1177. PubMed ID: 16971728
    [No Abstract]   [Full Text] [Related]  

  • 15. Nocturnal acid breakthrough in perspective: let's not throw out the baby with the bath water.
    Castell DO
    Am J Gastroenterol; 2003 Mar; 98(3):517-8. PubMed ID: 12650778
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP; Johnston BT; Just RJ; Castell DO
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination drug therapy for gastroesophageal reflux disease.
    Cross LB; Justice LN
    Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary care for GEDR].
    Takeda H
    Nihon Rinsho; 2004 Aug; 62(8):1499-503. PubMed ID: 15344540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of proton pump inhibitors].
    Herszényi L; Tulassay Z
    Orv Hetil; 2001 Sep; 142(36):1953-61. PubMed ID: 11680100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Omeprazol and ezomeprazol pharmacokinetics, duration of antisecretory effect, and reasons for their probable changes in duodenal ulcer].
    Serebrova SIu; Starodubtsev AK; Pisarev VV; Kondratenko SN; Vasilenko GF; Dobrovol'skiĭ OV
    Eksp Klin Gastroenterol; 2009; (4):86-92. PubMed ID: 19960999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.